Choosing the optimal glucose lowering therapy (Analogs of GLP-1) in patients with diabetic kidney disease ultimately defines the success of the treatment regime (Figure 8)
Tirzepatide offers very high efficacy for weight loss (more than semaglutide, based on recent evidence) most likely due to its dual mechanism, while semaglutide has established itself as a leader with its proven cardiovascular benefits, said Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP
They are not dangerous and usually disappear within a few days to a week
Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children
It is worth being direct about the state of the evidence, because DSIP is a compound where the name promises more than the literature delivers
Trimethylamine N-oxide: a link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function